Birth control can be gender-affirming care, depending on why it’s being used and who’s using it. For many transgender men and nonbinary people, hormonal contraception serves a purpose that goes well beyond preventing pregnancy: suppressing menstruation. When periods cause significant distress because they conflict with a person’s gender identity, using birth control to stop them fits squarely within the WHO’s definition of gender-affirming care, which includes “any single or combination of social, psychological, behavioural or medical interventions designed to support and affirm an individual’s gender identity.”
Why Birth Control Is Used as Gender-Affirming Care
For transgender men and transmasculine people, getting a monthly period can be a recurring source of gender dysphoria. Menstruation is a bodily function closely associated with femaleness, and for someone whose gender identity doesn’t align with that, each cycle can feel distressing. Hormonal birth control offers a way to reduce or eliminate periods, sometimes years before a person starts testosterone therapy or as an alternative to it entirely.
In a qualitative study published in the Journal of Adolescent Health, transgender and nonbinary young adults described using hormonal contraception specifically to suppress menstruation before they had access to testosterone. As one 22-year-old trans man put it: “A lot of people that I’ve talked to who are trans masculine or who are born with ovaries said that they had done birth control as a preventative measure for getting their period before they had access to testosterone.” Others used it alongside testosterone, or chose it as their only medical intervention.
Pregnancy prevention still matters too. The American College of Obstetricians and Gynecologists is clear that gender-affirming hormone therapy, including testosterone, is not effective contraception. Sexually active trans men with a uterus and ovaries who are exposed to sperm can still become pregnant on testosterone. So birth control sometimes serves a dual purpose: preventing pregnancy while also reducing dysphoria from menstrual bleeding.
Which Methods Are Most Common
Not all birth control methods work equally well for menstrual suppression, and some carry features that can actually worsen dysphoria. A study in the Journal of Pediatric and Adolescent Gynecology looked at contraceptive choices among transmasculine patients and found that injectable progesterone was the most popular option, used by 56% of patients. Oral pills came in second at 20%, followed by a progestin-only pill at 18% and hormonal IUDs at 4%.
The injectable option is popular for several reasons. Roughly 60% to 80% of users experience menstrual suppression, it only requires a shot every three months, and it’s completely concealed. There’s no daily pill to serve as a reminder of the body one is trying not to think about, and no device that requires an internal exam to place.
Progestin-only methods are generally preferred over combination pills (which contain both estrogen and progestin) because estrogen can cause breast tenderness and other effects that feel feminizing. That said, combination pills were still the second most commonly used method in the study population, likely because they’re widely available and familiar. When used continuously, skipping the placebo week, combination pills can also suppress periods effectively.
The subdermal implant, a small rod inserted under the skin of the upper arm, is another strong option. It has a failure rate of about 0.05%, similar to an IUD or permanent sterilization, and doesn’t require an internal exam. Hormonal IUDs are highly effective but do require insertion through the cervix, which some trans men find intolerable due to dysphoria around that anatomy.
How Dysphoria Shapes Contraceptive Choices
Clinicians who work with transgender patients consider a specific set of factors when recommending birth control. The British Columbia Medical Journal outlines several contributors to dysphoria that can affect contraceptive decisions: whether the method requires internal exams, whether it causes breakthrough bleeding, whether it needs to be taken daily (creating a recurring reminder), whether it has feminizing side effects like breast tenderness, how easy it is to stop, and whether the method is concealable.
These considerations matter in ways they typically don’t for cisgender women. A method that causes irregular spotting might be mildly annoying for one person and deeply distressing for another. A daily pill might feel neutral to a cisgender woman but serve as a daily confrontation with unwanted biology for a trans man. Some transmasculine people also express concern about using hormonal contraception while on testosterone, worrying it could counteract testosterone’s masculinizing effects. Research suggests this concern is largely unfounded for progestin-only methods, which work through different biological pathways than testosterone, but the worry itself is real and affects decisions.
The Line Between Contraception and Gender-Affirming Care
Whether birth control “counts” as gender-affirming care often depends on context, and sometimes on who’s defining it. The same IUD placed in a cisgender woman for pregnancy prevention and in a trans man for menstrual suppression is the same device, the same procedure, and the same medication. What differs is the clinical purpose.
This distinction matters for insurance coverage and access. Under the Affordable Care Act, contraception for pregnancy prevention is covered without cost-sharing for most insured people. Gender-affirming care coverage varies dramatically by state, insurer, and plan. In some cases, a provider might document the primary reason for prescribing birth control as menstrual management or dysphoria treatment rather than contraception, or vice versa, depending on which framing provides better coverage. The coding and billing landscape for gender-affirming services remains inconsistent across payers.
From a medical standpoint, the WHO’s broad definition leaves room for birth control to qualify. If the purpose is to affirm a person’s gender identity by eliminating a distressing bodily function, it fits. If the same person also needs pregnancy prevention, both purposes can coexist. Gender-affirming care isn’t a single treatment or procedure. It’s a framework that includes any medical intervention aimed at aligning a person’s body or experience with their identity.
Testosterone Is Not Birth Control
One critical point that comes up repeatedly in clinical guidelines: testosterone suppresses menstruation in many users, but it does not reliably prevent pregnancy. ACOG’s guidance states that sexually active individuals with retained gonads should be counseled about pregnancy risk even while on testosterone. The CDC notes that evidence on how testosterone interacts with hormonal contraceptives is still limited, but the consensus is clear that testosterone alone should not be relied on for contraception.
This means that for sexually active trans men who could become pregnant, birth control serves both a gender-affirming and a medically necessary contraceptive role. Some patients use hormonal birth control before starting testosterone, switch to testosterone and discontinue it, then later realize they still need contraception. Others layer both, using a progestin-only method or a copper IUD (which contains no hormones at all) alongside testosterone therapy. Permanent options like tubal ligation or hysterectomy, which some patients pursue as part of their gender-affirming surgical plan, also provide permanent contraception as a secondary benefit.